CEPR - Center for Economic and Policy Research


En Español

Em Português

Other Languages

Home Publications Blogs Beat the Press Government Intervention Makes Cancer Treatment Expensive

Government Intervention Makes Cancer Treatment Expensive

Wednesday, 20 October 2010 04:14
The NYT had an interesting piece this morning on how insurers are trying to reduce the cost of treating cancer. While the piece notes that much of the cost is related to the high price of new cancer drugs it would have been worth mentioning that this is the result of government granted patent monopolies. If the government used a different mechanism for financing drug development and allowed drugs to be sold at the free market price, all of these treatments would be relatively low cost. The doctors would be able to choose the one that they viewed as best for their patient without worrying about the cost.
Comments (2)Add Comment
written by izzatzo, October 20, 2010 7:30
From the NYT article, this quote:
And oncologists can reap tremendous profits, sometimes earning more than half of their income on the difference between what they pay for chemotherapy drugs and what they charge the insurers for the patient’s treatment plan.

When insurers start cracking down on the economic rents of doctors to increase their own rents, which in turn reduces the rents of Big Pharma as well, this is socialism plain and simple generated under health reform.

Talk about death panels, oncologists and their patients are at the bottom of the rent-food-chain, literally getting the life squeezed out of them as they're picked off one by one by the socialists.

Stupid liberals.
written by cheap sunglasses, October 24, 2010 5:44
There are
cheap sunglasses unusual preferential benefit, moreover the quality is also very good.

Write comment

(Only one link allowed per comment)

This content has been locked. You can no longer post any comments.


Support this blog, donate
Combined Federal Campaign #79613

About Beat the Press

Dean Baker is co-director of the Center for Economic and Policy Research in Washington, D.C. He is the author of several books, his latest being The End of Loser Liberalism: Making Markets Progressive. Read more about Dean.